摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-N-[2-(4-chlorophenyl)ethyl]-6-methyl-2-N-propan-2-yl-1,3,5-triazine-2,4-diamine

中文名称
——
中文别名
——
英文名称
4-N-[2-(4-chlorophenyl)ethyl]-6-methyl-2-N-propan-2-yl-1,3,5-triazine-2,4-diamine
英文别名
——
4-N-[2-(4-chlorophenyl)ethyl]-6-methyl-2-N-propan-2-yl-1,3,5-triazine-2,4-diamine化学式
CAS
——
化学式
C15H20ClN5
mdl
——
分子量
305.8
InChiKey
KJPSUAYTSCFZKL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    21
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    62.7
  • 氢给体数:
    2
  • 氢受体数:
    5

文献信息

  • Compositions and Methods for Treating Metabolic Disorders
    申请人:Elcelyx Therapeutics, Inc.
    公开号:US20140193498A1
    公开(公告)日:2014-07-10
    Compositions and methods for improving the pharmacokinetics and reducing the risk of adverse events resulting from biguanide compound administration are provided, comprising administering delayed release formulations of such compounds having a lag phase release.
    本发明提供了用于改善双胍类化合物的药代动力学并减少由其使用导致的不良事件风险的组合物和方法,包括给予延迟释放配方的这种化合物,其具有滞后释放阶段。
  • US20140341986A1
    申请人:——
    公开号:US20140341986A1
    公开(公告)日:2014-11-20
  • Biguanide Compositions and Methods of Treating Metabolic Disorders
    申请人:Elcelyx Therapeutics, Inc.
    公开号:US20170209394A1
    公开(公告)日:2017-07-27
    Provided herein are methods for treating certain conditions, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administrating a composition comprising a a biguanide or related heterocyclic compound, e.g., metformin. Also provided herein are biguanide or related heterocyclic compound compositions, and methods for the preparation thereof for use in the methods of the present invention. Also provided herein are compositions comprising metformin and salts thereof and methods of use.
  • BIGUANIDE COMPOSITIONS AND METHODS OF TREATING METABOLIC DISORDERS
    申请人:Anji Pharma (US) LLC
    公开号:US20220151957A1
    公开(公告)日:2022-05-19
    Provided herein are methods for treating certain conditions, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administrating a composition comprising a biguanide or related heterocyclic compound, e.g., metformin. Also provided herein are biguanide or related heterocyclic compound compositions, and methods for the preparation thereof for use in the methods of the present invention. Also provided herein are compositions comprising metformin and salts thereof and methods of use.
  • US9481642B2
    申请人:——
    公开号:US9481642B2
    公开(公告)日:2016-11-01
查看更多